Vitiligo & Repigmentation Protocol
Vitiligo & Repigmentation Protocol framework focused on consistent execution, practical monitoring, and safer progression.
An immune-targeted and melanogenic protocol for vitiligo combining autoimmune suppression with melanocyte stimulation to promote repigmentation of depigmented skin.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Vitiligo & Repigmentation Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
12-18 months; afamelanotide implants every 2 months alongside phototherapy
Target Audience
Vitiligo patients undergoing phototherapy (NB-UVB or PUVA) under dermatologist supervision
| Compound | Dose | Frequency |
|---|---|---|
| Melanotan 1 MC1R activation for melanogenesis stimulation | 16 mg implant | Every 2 months (subcutaneous implant) |
| Thymosin Alpha-1 Th1 autoimmune suppression protecting melanocytes | 1.6 mg | Twice weekly |
| GHK-Cu Melanocyte migration and dermal cell differentiation | 2 mg | Daily topical or SC |
| KPV Local perifollicular CD8+ T-cell infiltrate suppression | 500 mcg | Daily (topical preferred) |
| BPC-157 Dermal microvasculature restoration in depigmented areas | 250 mcg | Daily |
Free Peptide Guide
Vitiligo & Repigmentation Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned Melanotan 1 timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Vitiligo & Repigmentation Protocol run before reassessment?
A common window is 12-18 months; afamelanotide implants every 2 months alongside phototherapy, with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with Melanotan 1 + Thymosin Alpha-1 execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
Melanotan I (afamelanotide) directly stimulates MC1R on melanocytes to increase melanin synthesis, and clinical trials have demonstrated repigmentation when combined with phototherapy in vitiligo patients. Thymosin Alpha-1 targets the Th1-driven autoimmune destruction of melanocytes, the primary pathogenic mechanism in vitiligo, by restoring T-regulatory cell function. GHK-Cu promotes skin cell differentiation and migration of melanocytes from hair follicle reservoirs into depigmented patches. KPV provides local anti-inflammatory suppression of the perifollicular CD8+ T-cell infiltrate that destroys melanocytes. BPC-157 restores the dermal microvasculature needed to support repigmenting skin.
Clinical Research
No clinical references were provided for this stack yet.
More Skin & Cosmetic Stacks
Advanced Cosmetic Anti-Aging Topical Stack
Comprehensive topical peptide system targeting expression lines, skin laxity, collagen degradation, and oxidative damage. Suitable for daily facial and neck application.
Advanced Skin Rejuvenation & Anti-Aging Cosmetic Protocol
Comprehensive cosmetic peptide protocol targeting collagen synthesis, wrinkle reduction, skin elasticity, hyperpigmentation, and epidermal regeneration for clinically significant anti-aging skin improvement.
Comprehensive Anti-Aging Skincare Stack
A complete multi-peptide topical skincare system targeting all major aging mechanisms: collagen loss, expression lines, photo-aging, inflammation, and loss of skin firmness for comprehensive facial rejuvenation.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Vitiligo & Repigmentation Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.